vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and GigaCloud Technology Inc (GCT). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $332.6M, roughly 1.5× GigaCloud Technology Inc). GigaCloud Technology Inc runs the higher net margin — 11.2% vs -10.1%, a 21.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 9.7%). GigaCloud Technology Inc produced more free cash flow last quarter ($77.1M vs $-69.0M). Over the past eight quarters, GigaCloud Technology Inc's revenue compounded faster (36.6% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

GigaCloud Technology Inc. is an American e-commerce company that helps retailers buy and sell big and bulky, non-standardized items such as furniture, appliances, and fitness equipment. They own a business-to-business online marketplace and act as a middleman by handling sales, logistics and also delivery to end customers. GigaCloud is headquartered in El Monte, California, and is listed on the Nasdaq stock exchange since August 2022.

CLOV vs GCT — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.5× larger
CLOV
$487.7M
$332.6M
GCT
Growing faster (revenue YoY)
CLOV
CLOV
+35.1% gap
CLOV
44.7%
9.7%
GCT
Higher net margin
GCT
GCT
21.3% more per $
GCT
11.2%
-10.1%
CLOV
More free cash flow
GCT
GCT
$146.0M more FCF
GCT
$77.1M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
GCT
GCT
Annualised
GCT
36.6%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CLOV
CLOV
GCT
GCT
Revenue
$487.7M
$332.6M
Net Profit
$-49.3M
$37.2M
Gross Margin
23.2%
Operating Margin
-10.1%
12.2%
Net Margin
-10.1%
11.2%
Revenue YoY
44.7%
9.7%
Net Profit YoY
-123.2%
-8.6%
EPS (diluted)
$0.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GCT
GCT
Q4 25
$487.7M
Q3 25
$496.6M
$332.6M
Q2 25
$477.6M
$322.6M
Q1 25
$462.3M
$271.9M
Q4 24
$337.0M
$295.8M
Q3 24
$331.0M
$303.3M
Q2 24
$356.3M
$310.9M
Q1 24
$346.9M
$251.1M
Net Profit
CLOV
CLOV
GCT
GCT
Q4 25
$-49.3M
Q3 25
$-24.4M
$37.2M
Q2 25
$-10.6M
$34.6M
Q1 25
$-1.3M
$27.1M
Q4 24
$-22.1M
$31.0M
Q3 24
$-9.2M
$40.7M
Q2 24
$7.4M
$27.0M
Q1 24
$-19.2M
$27.2M
Gross Margin
CLOV
CLOV
GCT
GCT
Q4 25
Q3 25
23.2%
Q2 25
23.9%
Q1 25
23.4%
Q4 24
22.0%
Q3 24
24.5%
25.5%
Q2 24
30.3%
24.6%
Q1 24
23.6%
26.5%
Operating Margin
CLOV
CLOV
GCT
GCT
Q4 25
-10.1%
Q3 25
-4.9%
12.2%
Q2 25
-2.2%
11.1%
Q1 25
-0.3%
10.4%
Q4 24
-6.4%
9.3%
Q3 24
-2.7%
13.4%
Q2 24
2.0%
8.8%
Q1 24
-6.5%
13.9%
Net Margin
CLOV
CLOV
GCT
GCT
Q4 25
-10.1%
Q3 25
-4.9%
11.2%
Q2 25
-2.2%
10.7%
Q1 25
-0.3%
10.0%
Q4 24
-6.6%
10.5%
Q3 24
-2.8%
13.4%
Q2 24
2.1%
8.7%
Q1 24
-5.5%
10.8%
EPS (diluted)
CLOV
CLOV
GCT
GCT
Q4 25
Q3 25
$0.99
Q2 25
$0.91
Q1 25
$0.68
Q4 24
$0.76
Q3 24
$0.98
Q2 24
$0.65
Q1 24
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GCT
GCT
Cash + ST InvestmentsLiquidity on hand
$78.3M
$365.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$457.3M
Total Assets
$541.0M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GCT
GCT
Q4 25
$78.3M
Q3 25
$365.9M
Q2 25
$303.0M
Q1 25
$286.8M
Q4 24
$194.5M
$302.4M
Q3 24
$288.0M
$259.8M
Q2 24
$254.8M
$207.8M
Q1 24
$208.3M
$195.3M
Stockholders' Equity
CLOV
CLOV
GCT
GCT
Q4 25
$308.7M
Q3 25
$340.9M
$457.3M
Q2 25
$344.2M
$431.4M
Q1 25
$336.1M
$412.9M
Q4 24
$341.1M
$405.2M
Q3 24
$342.2M
$400.4M
Q2 24
$324.9M
$358.4M
Q1 24
$292.5M
$317.8M
Total Assets
CLOV
CLOV
GCT
GCT
Q4 25
$541.0M
Q3 25
$559.7M
$1.1B
Q2 25
$575.0M
$1.1B
Q1 25
$583.7M
$1.1B
Q4 24
$580.7M
$1.1B
Q3 24
$653.0M
$1.1B
Q2 24
$674.2M
$1.1B
Q1 24
$671.8M
$977.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
GCT
GCT
Operating Cash FlowLast quarter
$-66.9M
$78.3M
Free Cash FlowOCF − Capex
$-69.0M
$77.1M
FCF MarginFCF / Revenue
-14.1%
23.2%
Capex IntensityCapex / Revenue
0.4%
0.4%
Cash ConversionOCF / Net Profit
2.10×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$188.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
GCT
GCT
Q4 25
$-66.9M
Q3 25
$12.1M
$78.3M
Q2 25
$5.4M
$38.6M
Q1 25
$-16.3M
$9.4M
Q4 24
$34.8M
$68.4M
Q3 24
$50.0M
$55.2M
Q2 24
$44.8M
$19.1M
Q1 24
$25.9M
$15.3M
Free Cash Flow
CLOV
CLOV
GCT
GCT
Q4 25
$-69.0M
Q3 25
$11.4M
$77.1M
Q2 25
$4.8M
$37.0M
Q1 25
$-16.5M
$7.0M
Q4 24
$33.3M
$66.9M
Q3 24
$49.6M
$51.4M
Q2 24
$44.4M
$12.9M
Q1 24
$25.5M
$11.3M
FCF Margin
CLOV
CLOV
GCT
GCT
Q4 25
-14.1%
Q3 25
2.3%
23.2%
Q2 25
1.0%
11.5%
Q1 25
-3.6%
2.6%
Q4 24
9.9%
22.6%
Q3 24
15.0%
16.9%
Q2 24
12.5%
4.2%
Q1 24
7.3%
4.5%
Capex Intensity
CLOV
CLOV
GCT
GCT
Q4 25
0.4%
Q3 25
0.1%
0.4%
Q2 25
0.1%
0.5%
Q1 25
0.0%
0.9%
Q4 24
0.5%
0.5%
Q3 24
0.1%
1.3%
Q2 24
0.1%
2.0%
Q1 24
0.1%
1.6%
Cash Conversion
CLOV
CLOV
GCT
GCT
Q4 25
Q3 25
2.10×
Q2 25
1.12×
Q1 25
0.35×
Q4 24
2.21×
Q3 24
1.36×
Q2 24
6.04×
0.71×
Q1 24
0.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

GCT
GCT

Services$108.4M33%
Transferred Over Time$89.8M27%
Product Sales To B$50.1M15%
Last Mile Delivery Service$49.2M15%
Warehousing Service$14.2M4%
Ocean Transportation Service$9.0M3%
Platform Commission$4.9M1%
Drayage Service$3.2M1%

Related Comparisons